|Published||Report Code||Available Format||Pages|
Valued at $4.6 billion in 2017, the global cell isolation market is expected to generate $12.6 billion revenue by 2023, witnessing a CAGR of 18.8% during the forecast period (2018–2023).
The APAC cell isolation market is expected to register the fastest growth during the forecast period, owing to the high presence of clinical research organizations and biopharmaceutical companies. Developing economies, presence of giant biotechnology companies, and rise in the prevalence of chronic diseases are some of the other factors boosting the market growth in the region.
Factors Governing Cell Isolation Market
Cell separation or isolation techniques are used for the early detection of diseases and in the production of biopharmaceuticals, such as monoclonal antibodies, biosimilars, and recombinant proteins. Owing to hassle free production of biopharmaceuticals as compared to other pharmaceuticals, cell isolation is highly being used in healthcare industry. The cells are primarily obtained from human, animal, and plant sources, and hence require a more scrutinized filtration system in order to avoid contamination from viruses and bacteria. This facilitates the enhanced treatment of patients.
These biopharmaceuticals are used for the treatment of chronic diseases, mostly cancer. The high prevalence of cancer and other chronic diseases has led to an increase in the demand for biopharmaceuticals. The use of biopharmaceuticals in the early detection of cancer is gaining widespread attention in the medical industry. In addition, monoclonal antibodies are being used more commonly as these target irregular pathways and antigens that are generally present in cancers. Early diagnosis in such cases is the key to saving millions of cancer patients globally. Hereby, all these factors drive the growth of the cell isolation market.
Furthermore, the growing biopharmaceutical industry in developing nations, such as China and India, contributes as a key factor to market growth as these countries have a large population base. Thus, increased efficacy, ability to treat a wide range of diseases, and the development of the biopharmaceutical industry in the APAC countries are the major factors driving the demand for these biological structures.
Cell Isolation Market Segmentation Analysis
The consumables category led the cell isolation market in 2017 and is expected to grow faster during the forecast period. This leading position is mainly due to the requirement of various reagents, kits, media, sera, beads, and disposables for carrying out the process of cell isolation.
The human cell isolation category is expected to witness faster growth during the forecast period, owing to the advancement in stem cell technologies for the treatment of various diseases.
The centrifugation technique category accounted for the largest share in the cell isolation market in 2017. This is due to the low cost of centrifugation as compared to other techniques for cell isolation.
The biomolecule isolation category is expected to witness the fastest growth under the application segment during the forecast period. This is can be due to the increasing interest of pharmaceutical companies in the development of drugs based on biomolecules, owing to their less side effects.
The research laboratories and institutes category constituted the largest end user base for the cell isolation market in 2017 as cell isolation is most widely used for research purposes.
Geographical Analysis of Cell Isolation Market
North America was the largest region in the global cell isolation market in 2017. This is attributable to the presence of a large number of research laboratories, academic institutes, pharmaceutical and biotechnology companies, as well as hospitals and diagnostic laboratories that carry out extensive research that utilizes cell isolation instruments and consumables.
On the other hand, the APAC region is projected to witness fastest growth, owing to the increasing focus on basic and applied research by countries in this region. For example, many countries in this region, such as India and China, have established various research institutions to promote the advancement of cell-based research in their respective countries.
Competitive Landscape of Cell Isolation Market
The cell isolation market is consolidated in nature with several key players, including Thermo Fisher Scientific Inc., Merck KGaA, Beckman Coulter Inc., Terumo Corporation, GE Healthcare, STEMCELL Technologies Inc., Bio-Rad Laboratories Inc, and Becton, Dickinson and Company.
Major players operating in the cell isolation market are focusing on several strategic measures, such as product launches, mergers, acquisitions, and collaborations, to gain a competitive edge in the industry. For instance, in March 2018, Danaher Corporation entered into a definitive agreement to acquire Integrated DNA Technologies (IDT), a provider of high-value consumables for genomics applications in molecular biology, next-generation sequencing, qPCR, gene editing, synthetic biology, and molecular diagnostics. Through the acquisition, Danaher Corporation would expand its presence in genomics market and develop potential life-saving therapies and critical diagnostic tests.
Moreover, in February 2017, Thermo Fisher Scientific Inc. acquired Finesse Solutions Inc., a manufacturer of scalable control automation systems and developer of software for bioproduction. The business was integrated into Thermo Fisher’s Life Sciences Solutions Segment. The financial terms of the agreement were not disclosed.
Cell Isolation Market Size Breakdown by Segment
The cell isolation market report offers comprehensive market segmentation analysis along with market estimation for the period 2013–2023.
Based on Product
Based on Cell Type
Based on Technique
Based on Application
Based on End User
Key Questions Addressed in the Report